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Abstract The aim of this study was to evaluate preva-
lence of obstructive sleep apnea among patients undergo-
ing bariatric surgery and the predictive value of various
clinical parameters: body mass index (BMI), neck cir-
cumference (NC) and the Epworth Sleepiness Scale (ESS).
We performed a prospective, multidisciplinary, single-
center observational study including all patients on the
waiting list for bariatric surgery between June 2009 and
June 2010, irrespective of history or clinical findings.
Patients visited our ENT outpatient clinic for patient his-
tory, ENT and general examination and underwent a full
night polysomnography, unless performed previously. As
much as 69.9% of the patients fulfilled the criteria for OSA
(mean BMI 44.2 ± SD 6.4 kg/m2); 40.4% of the patients
met the criteria for severe OSA. The regression models
found BMI to be the best clinical predictor, while the ROC
curve found the NC to be the most accurate predictor of the
presence of OSA. The discrepancy of the results and the
poor statistical power suggest that all three clinical
parameters are inadequate predictors of OSA. In
conclusion, in this large patient series, 69.9% of patients
undergoing BS meet the criteria for OSA. More than 40%
of these patients have severe OSA. A mere 13.3% of the
patients were diagnosed with OSA before being placed on
the waiting list for BS. On statistical analysis, increased
neck circumference, BMI and the ESS were found to be
insufficient predictors of the presence of OSA. Polysom-
nography is an essential component of the preoperative
workup of patients undergoing BS. When OSA is found,
specific perioperative measures are indicated.
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Introduction
Obesity, declared a global epidemic by the World Health
Organization, is associated with a number of illnesses such
as diabetes, cardiovascular disease and cancer (http://
www.who.int) [1]. Equally, obesity is a significant risk
factor for obstructive sleep apnea (OSA), the most pre-
valent sleep disordered breathing problem. OSA affects
2–26% of the general population, depending on gender, age
and definition of the used criteria [2, 3]. To make matters
worse, obesity is dramatically on the rise. In 2005, 400
million adults worldwide were obese. The WHO projects
that in 2015, 700 million adults will be obese (http://
www.who.int).
The exact pathophysiology of OSA in obese patients
remains poorly understood, but it is thought that in obese
patients the local fatty tissue deposition in the neck results
in reduction of the lumen of the upper airway, thereby
reducing airflow and inducing airway collapse [4].
In patients with morbid obesity, who have failed con-
servative treatment, bariatric surgery (BS) can be consid-
ered. BS is not only the most effective, long-term treatment
modality in these patients for losing weight, but is also
known to have a positive effect on comorbidities. It is
therefore becoming increasingly popular. The benefits of
bariatric surgery are increasingly reported, but concern
about the safety is also heightened [5].
Patients with OSA are particularly vulnerable during
anesthesia and sedation and at an increased risk of devel-
oping respiratory and cardiopulmonary complications
postoperatively [6]. These risks can be decreased by ade-
quate management of the OSA. Furthermore, a recent study
by the Longitudinal Assessment of Bariatric Surgery group
(LABS) shows that a history of OSA is significantly
associated with an increased risk of major perisurgical
adverse outcomes in patients undergoing BS [5]. Addi-
tionally, OSA was found to triple the risk of perioperative
death in a recent single-surgeon report of 1000 Roux-en-Y
gastric bypass procedures [7].
Anesthetist and surgeons should be aware that undiag-
nosed OSA is common; OSA remains undiagnosed in an
estimated 93% of women and 82% of men [6, 8]. This
might hold true even more in the BS population.
Bearing this in mind, and with the aim of preventing
OSA-related complications of BS, we were interested to
see which percentage of patients undergoing bariatric
surgery in our clinic had OSA. Secondly, polysomnog-
raphies (PSG) are time consuming, costly and patient
burdensome. We were interested in measuring the predic-
tive value of various clinical parameters: body mass index
(BMI), neck circumference (NC) and Epworth Sleepiness
Scale (ESS).
Methods
Patients
We performed a prospective, multidisciplinary, single-
center observational study involving a consecutive series of
patients being evaluated for BS in our clinic from June
2009 until June 2010. Data collection for this study was
approved by the institution’s ethics committee. Patients
meeting the International Federation for the Surgery of
Obesity (IFSO) (http://www.ifso.com) criteria were eligi-
ble for BS, specifically patients aged 18–65 years, with a
BMI [ 40 kg/m2 or BMI [ 35 kg/m2 with associated
comorbidity (e.g., hypertension, diabetes, OSA or joint
problems). Secondly, patients were required to have made
sufficient attempts at weight loss using conservative mea-
sures and must be motivated for dietary and behavior
modification. There was flexibility in these guidelines.
Some patients with a BMI \ 35 kg/m2 were also included
if comorbid disease was present. A few exceptions were
also made concerning the age restriction. Participants with
a previous diagnosis of OSA were not excluded from our
analysis. Various BS types are performed in our clinic:
laparoscopic gastric banding, Swedish type of adjustable
gastric banding (SAGB), laparoscopic gastric bypass and
gastric sleeve resection. All patients eligible for BS
underwent a mandatory preoperative screening for OSA in
addition to our routine preoperative workup. If the AHI
was greater than 15/h, CPAP was prescribed.
Apart from patients with OSA previously diagnosed
elsewhere, preoperatively all patients on the waiting list for
BS visited the ENT outpatient department. Information was
gained using patient history, ENT and general examination
and a full overnight polysomnography (PSG). Weight,
length (BMI) and NC at the level of the cricothyroid
membrane were measured. The following BMI grading
system was implemented: obese (BMI 30–34.9 kg/m2),
severely obese (BMI 35–39.9 kg/m2), morbidly obese
(BMI 40–49.9 kg/m2) and super obese (BMI [ 50 kg/m2)
http://www.ifso.com. The patients completed a question-
naire containing various questions concerning possible
daily or nocturnal symptoms, intoxications, medication and
medical history. The ESS was included in the question-
naire. Patients scored themselves on a scale of 0–3 on how
easily they would fall asleep in eight different situations,
giving an overall score between 0 and 24; the higher the
score, the sleepier was the individual [9].
Polysomnography
Besides patients with OSA previously diagnosed else-
where, all patients underwent a full night comprehensive
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sleep study using a digital Embla recorder (Flaga Medical
devices, Reykjavik, Iceland). This records the sleep
architecture (derived from electroencephalogram, electro-
oculogram and submental electromyogram), respiration
(thoracic and abdominal measurement), movements of
limbs, nasal airflow and the intensity of the snoring (the
last two measured by pressure sensor). Transcutaneous
pulse oximetry was used to monitor oxygen saturation
(SaO2) and heart rate [10].
The severity of OSAS is expressed in the apnea hypo-
pnea index (AHI). Obstructive apneas were defined as
cessation of airflow for at least 10s. Hypopneas were
defined as periods of reduction of [30% oronasal airflow
for at least 10s and a C4% decrease in oxygen saturation.
Arousals were not scored as hypopneas. The apnea/hypo-
pnea index (AHI) was calculated as the sum of total events
(apneas and hypopneas) per hour of sleep. An AHI of 5–15/
h is mild OSAS, an AHI of 15–30/h is moderate and
AHI [ 30/h is severe OSAS, as assessed by polysomnog-
raphy [2, 10].
Statistical analysis
Statistical analysis was performed using Microsoft Excel
and SPSS statistical software (version 18, SPSS Inc.,
Chicago, USA).
The distribution of recorded variables was characterized
by calculating the mean and standard deviation. Since
some parameters (especially the AHI) were expected to be
non-normally distributed, also the median and range were
calculated. Data are given for both the total study popu-
lation and subdivided for women and men. The results of
women and men were compared using an unpaired t test,
with additional non-parametric Mann–Whitney when
applicable. Differences were considered significant when
p \ 0.05.
The prevalence of OSA and OSA severity was subdi-
vided for obesity severity subgroups. The relation between
the AHI and patient characteristics was further evaluated
employing stepwise linear regression and binomial logistic
regression. A p value of \0.05 was considered to be sta-
tistically significant.
The sensitivity and specificity of the clinical predictor
variables for the presence versus absence of OSA (AHI [ 5/
h) and moderate to severe OSA (AHI [ 15/h) were used to
plot receiver operating characteristic (ROC) curves.
Results
A total of 289 consecutive patients were recruited. Ten
patients did not show up for their ENT outpatient clinic and
PSG appointment. Of the remaining 279 patients, 214
(76.7%) were women and 65 (23.3%) men. Patient baseline
characteristics are shown in Table 1.
An unpaired t test was conducted to compare baseline
characteristics in men and women. There was a significant
difference in the AHI (p \ 0.0003), AI (p \ 0.0004),
Arousal index (p \ 0.006), DI (p \ 0.0003), mean O2 sat-
uration (p = 0.001), minimum O2 saturation (p \ 0.0007)
and NC (p \ 0.0003) between men and women.
In our study population, men were found to have a
higher AHI, AI, arousal index and DI, and lower mean and
minimum O2 saturation (Table 2). Therefore, the male and
female study population should be analyzed independently.
Application of a non-parametric test provided no new
insights.
Table 1 Patient characteristics: clinical and polysomnographic
parameters
Patient characteristics Mean Median Range
Women 214 (76.7%) – –
Men 65 (23.3%) – –
Age (years) 45.1 ± 10.6 46.0 (17–67)
BMI (kg/m2) 44.2 ± 6.4 42.8 (33–66)
Neck circumference (cm) 42.6 ± 4.8 42.0 (34–59.8)
ESS 4.3 ± 3.8 3.0 (0–17)
AHI (per h) 23.9 ± 27.7 12.4 (0–142)
AI 11 ± 21.4 1.6 (0–127)
Arousal index (per h) 7.5 ± 8.4 5 (0–54.7)
Mean SaO2 (%) 93.8 ± 3.3 94.7 (74–99)
Minimum SaO2 (%) 80.8 ± 10.7 83.0 (50–95)
Desaturation index (DI) 16.3 ± 23.4 5.3 (0–106)
± indicates standard deviation
AI apnea index; AHI apnea hypopnea index; BMI body mass index,
ESS Epworth Sleepiness Scale; OSA obstructive sleep apnea; SaO2
oxygen saturation
Table 2 Patient characteristics subdivided for women and men
Patient characteristics Men Women
Age (years) 48.5 ± 9.3 44.0 ± 10.8
BMI (kg/m2) 44.3 ± 7.1 44.2 ± 6.2
Neck circumference (cm) 48.0 ± 3.9 41.2 ± 4.0
ESS 5.0 ± 4.2 4.2 ± 3.6
AHI (h-1) 45.9 ± 29.9 17.3 ± 23.3
AI (h-1) 25.7 ± 27.1 7.0 ± 17.5
Arousal index (h-1) 10.6 ± 8.9 6.7 ± 8.1
Mean SaO2 (%) 92.3 ± 3.0 94.1 ± 3.4
Minimum SaO2 (%) 74.6 ± 11.3 82.5 ± 9.9
Desaturation index (DI) 32.2 ± 26.8 11.8 ± 20.3
± indicates standard deviation
AI apnea index; AHI apnea hypopnea index; BMI body mass index,
ESS Epworth Sleepiness Scale; OSA obstructive sleep apnea; SaO2
oxygen saturation
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Three (1.1%) of the patients were obese, 75 (26.9%)
severely obese, 149 (53.6%) morbidly obese, 51 (18.3%)
super obese. OSA stratified by BMI and the severity of
OSA by BMI are depicted in Table 3 and Fig. 1, respec-
tively. A total of 112 (40.1%) patients underwent or are on
the waiting list for SAGB (average BMI 41 ± SD 4 kg/
m2), 155 (55.6%) laparoscopic gastric bypass (average
BMI 46.1 ± SD 6.7 kg/m2) and 12 (4.3%) gastric sleeve
surgery (average BMI 49.4 ± SD 8.5 kg/m2). A mere 37
(13.3%) patients had been previously diagnosed with
OSAS (AHI: 42.5 ± SD 27.2 per h) in our hospital (12 pts)
or elsewhere (25 pts) before being placed on the waiting
list for BS. Based on the PSG results, 195 (69.9%) patients
were diagnosed with OSA, specifically 67 (34.7%) with
mild OSA, 48 (24.9%) with moderate OSA and 78 (40.4%)
with severe OSA. 69.2% of the patients diagnosed with
OSA were female and 30.7% male.
Stepwise linear regression was performed with AHI as
the dependent variable. Independent variables evaluated
were the BMI, NC and ESS [adjusted R2 = 0.236;
F = 22.9, p \ 0.0001 (using the stepwise method)]. In
men, only the BMI was associated with the AHI (adjusted
R2 = 0.167; F = 10.2, p = 0.003). Addition of the NC
and ESS gave no significant improvement of the model. In
women, the BMI also had a strong predictive value.
Addition of NC made significant improvement to the
model, but ESS did not (adjusted R2 = 0.113; F = 11.5,
p \ 0.0001).
The AHI data are not strictly normally distributed.
However, also after normalizing the data with a square root
transformation, there was no improvement in the associa-
tion between NC, ESS and the dependent variable (AHI).
Binomial logistic regression was used to identify inde-
pendent variables associated with the presence or absence
of (1) an AHI greater than 5/h or (2) 15/h.
Results showed that in women, the BMI was the only
significant predictor of an AHI greater than 5/h (odds ratio
[OR] = 1.072, p = 0.018, 95% CI 1.012–1.135) and of an
AHI greater than 15/h ([OR] = 1.102, p = 0.001, 95% CI
1.042–1.165). In men, NC was a significant predictor of an
AHI greater than 15/h ([OR] = 1.278, p = 0.026, 95% CI
1.030–1.586). No significant predictor was found for AHI
greater than 5/h.
The results of the ROC curves were disappointing; of all
three clinical parameters, no cutoff values were found to
have both a sensible sensitivity ([0.8) and a useful speci-
ficity ([0.9). No difference was seen between men and
women.
The neck circumference was found to be the most
accurate predictor of the presence of OSA when the AHI as
greater than 5/h (Fig. 2). The same was found when pre-
dicting an AHI greater than 15/h (Fig. 3).
Discussion
In this series of consecutive patients undergoing BS, we
found a 69.9% prevalence of OSA. More than 40% of these
patients were diagnosed with severe OSA. Of the 195
patients diagnosed with OSA, 69.2% were female: a 1:2.3
ratio (#:$), which is opposite to the typical OSA male
female ratio of 2:1 (#:$) [2]. The raised percentage of
women with OSA is caused by a skewed gender distribu-
tion within our study population. More than three-quarters
of our study population was female; comparative to earlier
reports that women seek surgical weight loss treatment
nearly four times more often than men [11].
Unlike many other studies, we used no selective inclu-
sion criteria such as the ESS as a screening tool.
Table 3 Number of patients with OSA stratified by BMI
OSA stratified by BMI OSA No
OSA
Total
no.
OSA
(%)
Obese (30–34.9 kg/m2) 1 2 3 33.3
Severely obese (35–39.9 kg/m2) 49 26 75 65.3
Morbidly obese (40–49.9 kg/m2) 103 46 149 69.1
Super obese ([50 kg/m2) 41 10 51 80.4
BMI body mass index, OSA obstructive sleep apnea
Fig. 1 Severity OSA stratified by BMI
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Irrespective of history or clinical findings, all patients being
evaluated for BS underwent a polysomnography, unless
performed previously.
Our results are consistent with similar studies (see
Table 3). Using synonyms for: bariatric surgery, obstruc-
tive sleep apnea and polysomnography, an online system-
atic search was performed of the MEDLINE and EMBASE
database on the 4th April 2011. Ten relevant articles were
found. In each study, all patients being evaluated for ba-
riatric surgery underwent a polysomnography as part of
routine screening for OSA regardless of symptoms and
without use of screening tools such as the ESS.
Four articles were omitted from our overview (see
Table 4), owing to various applied inclusion criteria (a
BMI C 40 kg/m2 or Asian race) and articles, which did not
apply the AASM OSA guidelines [12–15].
To our knowledge, following Sareli et al. and Lopez
et al. [16, 17], our group researched the third largest study
population. Together with O’Keeffe et al. [18], the above-
mentioned authors report a prevalence of 77–78%. Our
results are more in line with the results of Frey et al. and
Lee et al., but it should be noted that Lee et al. studied a
predominantly Asian population [19, 20]. Hallowell stands
out with a staggering 91% prevalence [21].
Several studies reported that the prevalence of OSA
increased as the BMI increased, which may explain why
our prevalence was lowest of all [17, 18]. In contrast, we
measured a high percentage of patients with severe OSA.
We have two main study limitations, the first being that
OSA was an inclusion criterion for bariatric surgery, in
accordance with the IFSO guidelines: a potential bias,
which could result in an overestimation of the prevalence
Fig. 2 ROC curve comparing sensitivity and specificity of neck
circumference (NC), body mass index (BMI) and Epworth Sleepiness
Scale (ESS) of an AHI [ 5/h. The mean area under the curve (AUC)
for NC, BMI and ESS were 0.69 ± 0.4 (95% CI 0.62–0.77),
0.61 ± 0.4 (95% CI 0.53–0.69), 0.54 ± 0.4 (95% CI 0.45–0.62),
respectively. No cutoff values were found to have both a sensible
sensitivity ([0.8) and a useful specificity ([0.9)
Fig. 3 ROC curve comparing sensitivity and specificity of neck
circumference (NC), body mass index (BMI) and Epworth Sleepiness
Scale (ESS) of an AHI [ 15/h. The mean area under the curve (AUC)
for NC, BMI and ESS were 0.76 ± 0.4 (95% CI 0.69–0.82),
0.62 ± 0.4 (95% CI 0.54–0.69) and 0.59 ± 0.4 (95% CI
0.51–0.67), respectively. No cutoff values were found to have both
a sensible sensitivity ([0.8) and a useful specificity ([0.9)
Table 4 Outcomes of similar studies, in which all patients being
evaluated for bariatric surgery underwent a polysomnography, irre-
spective of history or clinical findings
Reference Total
n
OSA
n
Prevalence
OSA (%)
Severe
OSA
(%)
Mean
AHI
(h-1)
Mean
BMI
(kg/m2)
Frey et al.
[19]
41 29 71.0 21.0 23.0 47.0
O’Keeffe
et al. [18]
170 131 77.0 23.7 – –
Lopez et al.
[17]
290 227 78.0 38.3 – 52.0
Hallowell
et al. [21]
249 227 91.0 – – 49.0
Sareli et al.
[16]
342 264 77.2 27.2 24.9 49.5
Lee et al.
[20]
176 126 71.6 48.0 28.0 42.0
All 1268 1004 79.2 33.1a 25.7b 48.8c
AHI apnea hypopnea index, BMI body mass index, OSA obstructive
sleep apnea
a Only studies presenting percentage severe OSA data
b Only studies presenting mean AHI data
c Only studies presenting mean BMI data
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of OSA in our bariatric surgery population. A mere 13.3%
(37) patients were diagnosed with OSA before being placed
on the waiting list for BS; 62.2% of these patients had a
BMI greater than 40 kg/m2 and were therefore eligible for
BS regardless of the presence of OSA. Four of the
remaining patients with a BMI smaller than 40 kg/m2, had
no other comorbid disease than OSA. The rest also suffered
from hypertension, diabetes or had joint problems. As this
group was minimal, we chose to include these patients in
the series so as to avoid underestimating the prevalence of
OSA in our bariatric surgery population.
The second limitation of the study is absent data, in
particular from patients who had previously been diag-
nosed with OSA elsewhere. These patients did not visit our
outpatient department, consequently patient information
such as ESS or NC was unavailable. We also had limited
access to their specific PSG data. ESS data were available
for 78.5% of the patients, and NC measurements for
82.4%.
ESS is considered a useful screening tool for OSA in the
adult population; but as reported by Sareli et al. [16], in the
bariatric population, ESS cannot independently reliably
predict the presence of OSA. Our data support this obser-
vation; we found ESS not to be significantly related to the
presence of OSA in patients undergoing BS. Hence, ESS is
not a reliable predictor of OSA in this patient population,
despite often being used in BS centers as a screening tool
[21].
We used various statistical techniques to analyze the
data. The various regression models and the ROC curves
give discrepant results, mainly due to the non-normal dis-
tribution of the data and data values of zero or close to
zero.
The poor statistical power and discrepancy of the results
strengthen our defense. We contend that all three clinical
parameters are inadequate predictors of OSA and that PSG
is an essential component of the preoperative workup of
patients undergoing BS. Despite the high test probability of
moderate to severe OSA in obese patients, the high costs
and patient burden of PSGs as well as the increasing
prevalence of obesity and BS, the Task Force of the AASM
does not advise the use of unattended portable monitoring
(PM) for general screening, as there is yet insufficient
evidence to guide the use of PM [22].
A recent, unique study by Hallowell et al. compared a
series of consecutive patients who underwent mandatory
OSA evaluation with a second group who were selected for
a preoperative sleep study based on clinical suspicion and a
raised ESS in preparation for the bariatric surgery program.
The authors suggest that OSA is grossly underdiagnosed in
the bariatric population and concludes that clinical evalu-
ation including the ESS is inadequate to identify the true
prevalence of OSA [20].
We found that a substantial number of patients, even
patients with extremely high AHIs, were completely una-
ware of their OSA. A mere 13.3% of the patients were
diagnosed with OSA before being placed on the waiting list
for BS; 37 (13.3%) patients had an AHI [ 60/h and only
11 patients were aware of their extreme OSA. Patients are
often asymptomatic or relate complaints of fatigue and
hypersomnolence to their obesity and/or other comorbidi-
ties (e.g., diabetes) and do not realize that these are actually
OSA related. More often than in the general population,
these patients sleep/live alone and a history of a bed partner
is often lacking, which collaborates with patients being
often unaware of their breathing abnormalities during
sleep.
The finding of OSA may in fact influence the indication
for BS being a BMI [ 40 kg/m2 in patients without
comorbidity, or BMI [ 35 kg/m2 with comorbidity.
Therefore, in otherwise healthy patients with a BMI
between 35 kg/m2 and 40 kg/m2, the finding of OSA
widens the indication for BS.
The finding of OSA has important perioperative impli-
cations. Patients with OSA have been shown to have
increased preoperative risk and specific perioperative
measures have to been taken [4, 23].
All patients with moderate to severe OSA should have
perioperative CPAP therapy [23]. To what extent periop-
erative CPAP therapy should also be applied in mild OSA
remains to be elucidated.
Intubation might be difficult, and specific methods of
intubation can be indicated. In case intubation is impossi-
ble and a tracheostomy must be performed, longer than
usual tracheal cannulas might be necessary [6]. Postoper-
atively, the use of morphinomimetic painkillers and other
muscle tone reducing medication is contraindicated in
patients with OSA, or can only be used with postoperative
monitoring [23].
Conclusion
We conclude that 69.9% of patients undergoing BS meet
the criteria for OSA. More than 40% of these patients have
severe OSA. Increased neck circumference, BMI or ESS
cannot reliably predict the presence of OSA. Polysom-
nography is an essential component of the preoperative
workup of patients undergoing BS. When OSA is found,
specific perioperative measures are indicated. We are cur-
rently following these patients and aim to publish a paper
showing the results of postoperative PSG results shortly.
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